Roflumilast cream 0.15% was associated with consistent and meaningful improvements in AD clearance and itch reduction, according to new data.
All News
Advertisement
Advertisement
The risk of gestational diabetes was 2-fold greater among young women with prediabetes before conceiving compared with those who had normoglycemia.
A continuous increase in ASCVD risk was seen with higher levels of lipoprotein(a) in the largest study to date of the relationship.
Your daily dose of the clinical news you may have missed.
How are you managing your patients with resistant or refractory hypertension? How do your strategies align with current guidelines? Try these 9 questions and find out.
Elinzanetant for Menopausal VMS: OASIS Lead Investigator Discusses Results, Side Effects, Next Steps
JoAnn Pinkerton, MD, details the positive findings from the OASIS 1, 2, and 3 studies of elinzanetant and highlights next steps in research.
Delgocitinib specifically inhibits activation of JAK-STAT signaling in chronic hand eczema and would be an option for people unable to use topical corticosteroids.
Your daily dose of the clinical news you may have missed.
One in 9 primary care encounters involved a mental health condition, according to an analysis of over 350 million primary care visits.
The AI-based point-of-care device outperformed clinician standard of care for sensitivity (90% vs 40%) and had a negative predictive value of 98.9%
Advertisement
Adults saying they don't need immunization this fall have received the vaccines in the past, survey authors report, suggesting a lingering misinformation effect.
Your daily dose of the clinical news you may have missed.
Erenumab 140 mg safely and effectively induced remission in nonopioid MOH within 6 months in individuals for whom other preventive medications had failed.
FluMist is the first influenza vaccine that does not have to be given by a health care professional.
The only CGM system cleared for 1 year of use in type 1 and 2 diabetes is expected to be available in the fourth quarter of this year, the manufacturers said.
New report includes data on the safety and immunogenicity of the recently-approved PCV21 vaccine.
Your daily dose of the clinical news you may have missed.
Immune responses for both vaccines were noninferior when given at the same visit compared with separate administration among adults aged 50 years and older.
The positive pivotal phase 3 trial results showed improved lung function with neradomilast vs placebo and will support BI's US and global NDA submissions.
Your daily dose of the clinical news you may have missed.
Advertisement
Advertisement
Advertisement